Sofina focuses on acquisition of minority stakes in private and listed companies and investment in venture and growth capital funds, with portfolio strengths in digital transformation (30%), consumer goods and services (27%), health and life sciences (13%), and education (11%). Geographically, the portfolio is distributed across Western Europe (36.6%), North America (37.1%), and Asia (26.2%).
Cyborg Score Rationale
Founded in 1898, Sofina has 125+ years of investment experience and diversified operational history. The company demonstrates strong positioning with portfolio valued at EUR 10,054.3 million as of end 2024 and strategic exposure to high-growth sectors including digital transformation and life sciences. Long-term holding strategy (10-12 years) and global reach provide stability.
Top Insights
Portfolio focus on digital transformation (30%) and consumer goods/services (27%) reflects exposure to secular growth trends
Balanced geographic diversification with nearly equal exposure to North America (37.1%) and Western Europe (36.6%)
Dual investment strategy through direct equity stakes and fund-of-funds approach provides multiple growth levers
Long-term investment horizon (10-12 years) enables patient capital approach aligned with venture and growth equity cycles
Named Competitors
Apax Partners — European private equity investor in mid-market companies
CVC Capital Partners — Global private equity and credit investor
Permira — Europe-focused private equity investor
Recent Developments
Portfolio valued at EUR 10.05 billion as of end-2024 with core exposure to digital transformation and consumer markets
Open the full interactive Sofina Société Anonyme report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.